Trial Profile
A trial to investigated whether primary tumor location affects cetuximab efficacy in patients with RAS wild-type (WT) metastatic colon cancer determined by extended RAS genotyping
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Colon cancer
- Focus Pharmacodynamics
- 08 Aug 2016 New trial record